Supplementary Figure 2 from KRAS Promotes GLI2-Dependent Transcription during Pancreatic Carcinogenesis

Ashley N. Sigafoos; Ezequiel J. Tolosa; Ryan M. Carr; Maite G. Fernández‐Barrena; Luciana L. Almada; David R. Pease; Tara L. Hogenson; Glancis L. Raja Arul; Fatemeh Mousavi; Sandhya Sen; Renzo E. Vera; David L. Marks; Luis F. Flores; Kayla C. LaRue-Nolan; Chen Wu; William R. Bamlet; Anne M. Vrabel; Hugues Sicotte; Erin L. Schenk; Thomas C. Smyrk; Lizhi Zhang; Kari G. Rabe; Ann L. Oberg; Peter G. Zaphiropoulos; Éric Chevet; Rondell P. Graham; Catherine E. Hagen; Marina Pasca di Magliano; Sherine F. Elsawa; Christopher L. Pin; Junhao Mao; Robert R. McWilliams; Martín E. Fernández-Zapico

doi:10.1158/2767-9764.26213840.v1

Abstract

Supplementary Figure 2 describes the characterization of the impact Gli2 overexpression in pancreas development. showing that Gli2 loss has no impact on pancreas development or survival in vivo.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Sigafoos et al. (2024) studied this question.

synapsesocial.com/papers/68e60f5cb6db6435875a1fab https://doi.org/10.1158/2767-9764.26213840.v1

View Full Paper

Ask AI

Bookmark

Abstract

Supplementary Figure 2 describes the characterization of the impact Gli2 overexpression in pancreas development. showing that Gli2 loss has no impact on pancreas development or survival in vivo.

Supplementary Figure 2 from KRAS Promotes GLI2-Dependent Transcription during Pancreatic Carcinogenesis

Abstract

Discussion

Cite This Study

Supplementary Figure 2 from KRAS Promotes GLI2-Dependent Transcription during Pancreatic Carcinogenesis

Abstract

Discussion

Cite This Study

Keep reading

Keep reading